BioLineRx BLRX
NASDAQ BLRX
$2.36 -0.07 (-2.88%)
As of: Sep 29, 2026 · 3:07 PM EDT

BioLineRx (BLRX) Total Debt (2011 - 2026)

Updated

BioLineRx's Total Debt was $6.7 million in the quarter ended Jun 30, 2026, down 40.2% from $11.2 million a year earlier and down 14.5% from the prior quarter.

Analysis

BioLineRx (BLRX) Total Debt (2011 - 2026) Analysis & Trends

As of Dec 31, 2025, Total Debt at BioLineRx came in at $8.94 million, down 33.5% from the prior year.

  • Total Debt shows a five-year compound annual growth rate of 8.9% (years ended Dec 2020 to Dec 2025).
  • In earlier years, Total Debt was $13.44 million in the year ended Dec 31, 2024 (+37.5%), $9.77 million in the year ended Dec 31, 2023 (-3.9%), $10.17 million in the year ended Dec 31, 2022 (+268.8%) and $2.76 million in the year ended Dec 31, 2021 (-52.7%).
  • The figure for the quarter ended Jun 30, 2026 marks the lowest quarterly Total Debt since the quarter ended Jun 30, 2022.
  • Compared with a year earlier, Total Debt has declined for five straight quarters, with an average decline of 3.6% over the last eight quarters.
  • The best year-over-year quarter for Total Debt over five years was the quarter ended Mar 31, 2023 (growth of 467.4%); the worst was the quarter ended Jun 30, 2022 (a decline of 76.8%).
  • Per Business Quant data, BLRX's Total Debt in the three quarters before the quarter ended Jun 30, 2026 was $7.84 million (quarter ended Mar 31, 2026), $8.94 million (quarter ended Dec 31, 2025) and $10.08 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 49.04 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 70.82 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 53.91 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 37.49 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -111.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 57.30 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 26.25 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 63.19 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 BioLineRx 6.34 Bn 6.35 Bn 235,000.00 6.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.70 Mn
Mar 31, 2026 7.84 Mn
Dec 31, 2025 8.94 Mn
Sep 30, 2025 10.08 Mn
Jun 30, 2025 11.20 Mn
Mar 31, 2025 12.32 Mn
Dec 31, 2024 13.44 Mn
Sep 30, 2024 27.80 Mn
Jun 30, 2024 29.45 Mn
Mar 31, 2024 9.62 Mn
Dec 31, 2023 9.77 Mn
Sep 30, 2023 11.54 Mn
Jun 30, 2023 11.57 Mn
Mar 31, 2023 10.80 Mn
Dec 31, 2022 10.17 Mn
Sep 30, 2022 9.16 Mn
Jun 30, 2022 1.01 Mn
Mar 31, 2022 1.90 Mn
Dec 31, 2021 2.76 Mn
Sep 30, 2021 3.58 Mn
API Access

BioLineRx Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=BLRX&period=max&api_key=YOUR_API_KEY